Literature DB >> 22658882

Prognostic significance of primary Gleason pattern in Japanese men with Gleason score 7 prostate cancer treated with radical prostatectomy.

Hideaki Miyake1, Mototsugu Muramaki, Junya Furukawa, Hirokazu Tanaka, Taka-aki Inoue, Masato Fujisawa.   

Abstract

OBJECTIVES: To evaluate the significance of the primary Gleason pattern in patients with Gleason score (GS) 7 prostate cancer treated with radical prostatectomy.
MATERIALS AND METHODS: This study included 959 consecutive Japanese men who underwent radical prostatectomy without neoadjuvant therapies and were subsequently diagnosed as having GS 7 prostate cancer based on the modified International Society of Urological Pathology (ISUP) 2005 Gleason grading system.
RESULTS: Of these 959 patients, 666 (69.4%) and 293 (30.6%) had GS 3+4 and GS 4+3 tumors, respectively. There were significant differences in the prostate-specific antigen (PSA) level, biopsy GS, pathologic T stage, lymphatic invasion, microvenous invasion, and perineural invasion between these 2 groups. During the mean observation of 48.9 months, biochemical recurrence occurred in 211 patients (22.0%), and there was a significant difference in the biochemical recurrence-free survival between patients with GS 3+4 tumors and those with GS 4+3 tumors. Of several factors examined, biochemical recurrence-free survival was significantly associated with the PSA level, biopsy Gleason score, capsular penetration, seminal vesicle invasion, surgical margin status, lymphatic invasion, microvenous invasion, perineural invasion, and primary Gleason pattern, among which the PSA level, capsular penetration, seminal vesicle invasion, and surgical margin status, but not primary Gleason pattern, appeared to be independent predictors of biochemical recurrence.
CONCLUSIONS: Despite the lack of an independent significance, primary Gleason pattern based on the modified ISUP 2005 Gleason grading system is shown to be significantly associated with the biochemical outcome of Japanese men with GS 7 prostate cancer.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Gleason score 7; Primary Gleason pattern; Prostate cancer; Radical prostatectomy

Mesh:

Substances:

Year:  2012        PMID: 22658882     DOI: 10.1016/j.urolonc.2012.05.001

Source DB:  PubMed          Journal:  Urol Oncol        ISSN: 1078-1439            Impact factor:   3.498


  5 in total

1.  The effect of Rapid Access Prostate Clinics on the outcomes of Gleason 7 prostate cancer: does earlier diagnosis lead to better outcomes?

Authors:  M P Broe; J C Forde; M S Inder; D J Galvin; D W Mulvin; D M Quinlan
Journal:  Ir J Med Sci       Date:  2017-03-09       Impact factor: 1.568

2.  Biochemical recurrence in Gleason score 7 prostate cancer in korean men: significance of the primary Gleason grade.

Authors:  Yun Kwan Ro; Sangchul Lee; Chang Wook Jeong; Sung Kyu Hong; Seok Soo Byun; Sang Eun Lee
Journal:  Korean J Urol       Date:  2012-12-20

3.  Discrimination between clinical significant and insignificant prostate cancer with apparent diffusion coefficient - a systematic review and meta analysis.

Authors:  Hans-Jonas Meyer; Andreas Wienke; Alexey Surov
Journal:  BMC Cancer       Date:  2020-05-27       Impact factor: 4.430

4.  Prognostic significance of six clinicopathological features for biochemical recurrence after radical prostatectomy: a systematic review and meta-analysis.

Authors:  Haoran Liu; Hui Zhou; Libin Yan; Tao Ye; Hongyan Lu; Xifeng Sun; Zhangqun Ye; Hua Xu
Journal:  Oncotarget       Date:  2017-11-06

5.  A critical evaluation of visual proportion of Gleason 4 and maximum cancer core length quantified by histopathologists.

Authors:  Lina Maria Carmona Echeverria; Aiman Haider; Alex Freeman; Urszula Stopka-Farooqui; Avi Rosenfeld; Benjamin S Simpson; Yipeng Hu; David Hawkes; Hayley Pye; Susan Heavey; Vasilis Stavrinides; Joseph M Norris; Ahmed El-Shater Bosaily; Cristina Cardona Barrena; Simon Bott; Louise Brown; Nick Burns-Cox; Tim Dudderidge; Alastair Henderson; Richard Hindley; Richard Kaplan; Alex Kirkham; Robert Oldroyd; Maneesh Ghei; Raj Persad; Shonit Punwani; Derek Rosario; Iqbal Shergill; Mathias Winkler; Hashim U Ahmed; Mark Emberton; Hayley C Whitaker
Journal:  Sci Rep       Date:  2020-10-14       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.